For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the ...

INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early ...

Amid claims of "digital dementia," experts explain that AI isn't declining. It's just stupid in the first place.

New research finds that diet, exercise, and stress management helped improve or stabilize brain function in early-stage ...

In the Phase 2 MINDFuL trial of XProTM in patients with early Alzheimer's Disease (AD) with biomarkers of inflammation, the modified intent-to-treat ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has closed its registered direct offering, announced on June 27, 2025, ...

It wasn’t that long ago when screaming “follow the science” was all the rage, even if the alleged science wasn’t remotely ...

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study ...

Alzheimer’s Pipeline Report, released by the Kirk Kerkorian School of Medicine at UNLV, reveals dozens of promising drug trials that could bring hope to millions of families. The research ...

I remember the first time I was on stage and scrambled my words. If my lines in a play were supposed to be "Sherwin-Williams, ...

Memory varies from person to person, but it may also deeply impact the quality of your life. While there are various factors influencing the change and decline in memory, age is among the leading ones ...

Some people with long COVID are turning to an unlikely remedy: nicotine gum and patches. Though typically used to quit ...